Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE +0.22%, DAX +0.43%, CAC40 +0.21%

Aug 13 ,2025

  • Synopsis

    • European equity markets are set for a positive open. Asian equity markets mostly higher with Nikkei hitting fresh record high. Decent gains for Hang Seng amid gains in tech stocks. US equity futures little changed. Follows firmer close in prior sessions with S&P posting record high and closing above 6,400 level for the first time.

    • In central banks, ECB publishes its latest Supervision newsletter at 10:00CET. Also, IEA oil market report is due.

    • Economic data set to be released include Germany and Spain Jul final CPI.

    • In earnings, a slew of DACHs region names updated investors including E.ON (EOAN.GR) out with H1 adjusted net income €1.93B vs FactSet €1.89B, confirms FY25 guidance and TUI Group (TUI1.GR) reporting Q3 underlying EBIT €321M vs StreetAccount €265.3M. Other companies out with results include Wienerberger (WIE.AV), Brenntag (BNR.GR), Straumann Holding (STMN.SW), Evotec (EVT.GR), Stroeer (SAX.GR) and Semperit Holding (SEM.AV). In Denmark, Demant (DEMANT.DC) reported H1 EBIT before special items DKK1.85B vs consensus DKK1.98B and revised outlook for 2025 revised for organic growth and EBIT and Vestas (VWS.DC) reported Q2.

    • Also due to report today are Vestas Wind Systems (VWS.DC), Beazley (BEZ.LN), Persimmon (PSN.LN), Balfour Beatty (BBY.LN) and Hill & Smith (HILS.LN).

  • Top company news

    • Earnings/updates

      • Benelux:

        • ENVI.NA (Envipco Holding) -- reports Q2 EPS (€0.04) vs FactSet (€0.01) [5 est, (€0.01)-0.00]

      • DACHs:

        • EOAN.GR (E.ON) -- reports H1 adjusted net income €1.93B vs FactSet €1.89B; fully confirms FY25 guidance and FY28 outlook, incl dividend policy

        • WIE.AV (Wienerberger) -- reports H1 net income €108M vs year-ago €0.55M; confirms FY EBITDA guidance of ~€800M (FactSet €788.7M)

        • TUI1.GR (TUI Group) -- reports Q3 underlying EBIT €321M vs StreetAccount €265.3M; notes positive start to Winter 2025/26 bookings overall

        • FRA.GR (Fraport) -- reports July Frankfurt Airport traffic statistics: passengers 6.1M, +1.y/y

        • MBTN.SW (Meyer Burger Technology) -- SIX grants Meyer Burger further extension to publish its annual report until the end of Aug-25

        • FYB.GR (Formycon) -- reports H1 adjusted EBITDA (€19.2M) vs year-ago (€2.1M)

        • GYC.GR (Grand City Properties) -- reports Q2 FFO I €0.54 vs year-ago €0.54; reaffirms FY guidance

        • SPG.GR (Springer Nature) -- expects FY revenue €1.93-1.96B vs prior guidance in the upper half of the range of €1.885-1.935B and FactSet €1.91B

        • BNR.GR (Brenntag) --reports Q2 EPS €0.30 vs year-ago €1.03; Operating gross profit, Operating EBITA and guidance in line with 11-Jul prelim announcement

        • STMN.SW (Straumann Holding) -- reports H1 core EPS CHF1.66 vs consensus CHF1.79 [5 est, CHF1.63-1.94]; Outlook 2025 confirmed

        • EVT.GR (Evotec) -- reports H1 EPS (€0.42) vs year-ago (€0.65); confirms FY25 guidance as per 21-Jul update

        • TTR1.GR (technotrans) -- reports H1 EPS €0.75 vs year-ago €0.34

        • SPG.GR (Springer Nature) -- reports H1 adjusted operating income €240.6M vs FactSet €237.4M [1 est]

        • PBB.GR (Deutsche Pfandbriefbank) -- reports Q2 net income (€266M) vs year-ago €11M

        • TPE.GR (PVA TePla) -- reports Q2 EPS €0.13 vs FactSet €0.20 [1 est]; guides FY to lower end of forecast ranges citing order postponements

        • NCH2.GR (thyssenkrupp nucera) -- reports Q3 EPS (€0.01) vs FactSet €0.04 [2 est, €0.03-0.04]

        • SAX.GR (Stroeer SE & Co. KGaA) -- reports Q2 adj EBITDA €148.9M vs consensus €150.9M; standing by its forecast for 2025

        • SEM.AV (Semperit Holding) -- reports Q2 net income (€4.0M) vs FactSet (€0.5M) [1 est]; reaffirms FY guidance

        • GSC1.GR (GESCO SE) -- reports H1 EPS €0.44 vs FactSet €0.40 [1 est] (

        • R3NK.GR (Renk Group) -- reports H1 adj net income €51.6M vs year-ago €30.2M; confirms its forecast for FY25

        • SIX2.GR (Sixt) -- reports Q2 EPS €1.67 vs FactSet €1.71 [2 est, €1.63-1.78]

        • BIKE.GR (Bike24 Holding) -- reports Q2 net income €0.2M vs year-ago (€2.2M); reaffirms FY guidance

        • ILM1.GR (Medios) -- reports H1 EPS €0.50 vs year-ago €0.27

      • Nordics:

        • DEMANT.DC (Demant) -- reports H1 EBIT before special items DKK1.85B vs consensus DKK1.98B; Outlook for 2025 revised for organic growth and EBIT

        • VWS.DC (Vestas Wind Systems) -- reports Q2 net income €43M vs consensus €58M; maintains FY25 outlook

        • NOD.NO (Nordic Semiconductor) -- reports Q2 net income $10.1M vs FactSet $5.5M [3 est, $3.3-7M]; guides Q3 and reiterates its long-term ambition

        • EMGS.NO (Electromagnetic Geoservices) -- reports Q2 EPS $0.00 vs year-ago $0.03

        • TAALA.FH (Taaleri) -- reports Q2 EPS €0.07 vs FactSet €0.03 [1 est]

        • SITOWS.FH (Sitowise Group) -- reports Q2 EPS (€0.01) vs FactSet €0.00 [3 est, (€0.03)-0.02]

    • M&A

      • NBG6.GR (N+£RNBERGER Beteiligungs-AG) -- Activist investor 7Square urges NÜRNBERGER Beteiligungs to consider rival bids -- Reuters

      • PSM.GR (ProSiebenSat.1 Media) -- holder General Atlantic tenders 2.4% stake to PPF - Reuters, citing people familiar with the matter

      • AGR.LN (Assura) -- Sana Bidco announces lapse of Assura offer

      • EMR Capital revives sale process for stake in Kestrel coal mine - The Australian

    • Healthcare

      • INSM (Insmed) -- FDA approves BRINSUPRI (brensocatib) as the first and only treatment for non-cystic fibrosis bronchiectasis

    • Other

      • SANN.SW (Santhera Pharmaceuticals Holding) -- secures agreement with GEN for the distribution of AGAMREE (Vamorolone) in Türkiye

      • AVOL.SW (Avolta) -- secures 12-year retail contract at San José International Airport

      • DANSKE.DC (Danske Bank) -- removes fossil fuel stocks from investment management universe (4:27 AM)

      • Venture Global releases statement on "positive" decision in arbitration with Shell

  • Key rating changes

    • Upgrades

      • HNR1.GR (Hannover Re) -- to neutral from underperform at Oddo

      • GEN.LN (Genuit Group) -- to outperform from sector perform at RBC Capital Markets

      • QLT.LN (Quilter) -- to buy from hold at Berenberg

    • Downgrades

      • ORSTED.DC (Ørsted) -- to hold from buy at ABG Sundal Collier

      • G1A.GR (GEA Group) -- to equal-weight from overweight at Morgan Stanley

      • LGEN.LN (Legal & General Group) -- to neutral from overweight at JPMorgan

      • WAWI.NO (Wallenius Wilhelmsen) -- to hold from buy at DNB Carnegie

      • WOSG.LN (Watches of Switzerland Group) -- hold from buy at Kepler Cheuvreux

    • Initiations

      • SFL.IM (Safilo Group) -- buy at Berenberg

      • AMS.SM (Amadeus IT Group) -- overweight at Cantor Fitzgerald

  • Data

    • Nikkei +1.39% to 43313.86

    • Hang Seng +2.01% to 25472.51

    • Shanghai Composite +0.49% to 3683.95

    • S&P futures +0.0 vs prior close of 6468.5

    • €-$ +0.0003 or +0.02% to 1.1680

    • $-¥ +0.11 or +0.08% to 147.95

    • €-¥ +0.17 or +0.10% to 172.77

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE